Regeneron Pharmaceuticals Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +22.4% | -6.8% | -12.7% | +52.0% | +137.9% | -21.0% | +22.5% | -1.3% | -10.5% | +38.2% | +60.0% | -28.4% | +10.6% | +47.0% | +21.5% | +57.2% | +41.8% | +31.2% | +44.9% | +24.3% | +25.7% | +33.9% | +26.2% | +15.9% | +48.2% | +14.9% | +13.2% | +14.1% | +7.4% | |
| – | +17.2% | -6.7% | -21.4% | +83.8% | +193.9% | -29.7% | +15.6% | +7.4% | -0.7% | +37.7% | +69.8% | -34.6% | -18.4% | +69.2% | +26.9% | +77.4% | +39.0% | +11.3% | +35.0% | +15.7% | +43.0% | +42.2% | -3.4% | +65.9% | +9.9% | +13.3% | +22.6% | -4.2% | -3.4% | |
| – | -16.2% | -31.5% | +19.7% | +30.7% | +698.6% | -67.6% | +47.7% | -14.4% | +82.3% | +28.9% | +109.7% | -50.3% | -16.4% | -45.6% | +329.6% | -52.4% | +132.6% | +21.1% | +24.7% | -33.9% | +51.9% | +80.6% | +10.2% | +35.6% | +31.5% | +7.6% | -12.1% | -8.9% | +25.3% | |
| – | -16.2% | -31.5% | +234.3% | +77.7% | +227.4% | -31.4% | +11.2% | +0.8% | +0.9% | +53.8% | +66.9% | -38.1% | -28.1% | -26.9% | +111.3% | -41.5% | +125.3% | +96.1% | +23.3% | -38.1% | +178.8% | +57.6% | -29.6% | +109.1% | -15.3% | +36.0% | +40.1% | -16.9% | -4.5% | |
| – | +53.5% | -13.6% | -89.5% | +2,205.8% | -78.5% | +35.0% | +286.6% | +177.6% | -15.3% | -79.5% | +144.5% | +92.2% | +86.2% | +24.9% | +25.8% | +572.7% | +37.8% | +6.5% | +44.3% | +9.8% | +22.5% | +13.6% | +24.2% | +47.7% | +46.7% | -11.7% | +6.4% | +9.6% | -7.6% | |
| – | – | – | – | -58.4% | +107.5% | +71.9% | +31.8% | -64.1% | -10.1% | – | – | – | – | – | – | +111.3% | +145.7% | +83.2% | +85.1% | +67.4% | +81.8% | +58.5% | +23.0% | +35.4% | +1.8% | +23.1% | +7.4% | +19.6% | +3.7% | |
| – | – | – | – | – | +6.8% | +94.8% | +5.1% | -11.7% | -15.0% | -18.5% | +18.1% | +50.7% | +195.6% | +33.8% | +5.9% | +3.3% | +38.7% | +84.9% | +63.6% | +30.7% | +13.2% | +9.2% | +12.2% | +11.5% | +8.1% | +8.1% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +13,564.2% | +13.4% | +10.6% | +9.5% | |
| – | -3.9% | -12.9% | +7.0% | -4.9% | +776.1% | +7.2% | +39.2% | -15.0% | +6.5% | +19.1% | +29.2% | -47.2% | +37.1% | +63.1% | +49.2% | -0.3% | +19.6% | +33.1% | +47.0% | +29.2% | +3.8% | +13.6% | +24.8% | +65.2% | +8.6% | -1.7% | +8.5% | +18.3% | +10.7% | |
| – | -10.8% | -12.1% | +41.5% | +3.7% | +59.7% | +82.2% | +81.8% | -53.2% | +18.2% | +11.5% | +530.2% | -70.5% | +11.8% | +16.5% | +36.0% | +10.3% | +82.7% | +107.5% | +22.7% | +63.2% | -22.1% | +39.8% | +55.1% | +33.9% | +40.1% | -20.1% | +9.0% | +15.2% | +10.8% | |
| – | -50.0% | -38.9% | +27.3% | -56.3% | -30.4% | -64.8% | +9,111.3% | +36.6% | +23.7% | -8.0% | +831.5% | -18.8% | – | – | +49.0% | +36.6% | -31.7% | +37,194.7% | +29.2% | -71.4% | +261.9% | -80.6% | – | – | -55.9% | +0.0% | – | – | – | |
| – | +6.8% | +19.1% | +17.9% | +43.1% | +57.0% | +104.4% | -37.5% | -0.3% | +23.7% | -8.0% | -62.1% | -22.9% | +197.4% | -16.4% | +77.9% | +40.4% | +59.1% | +60.7% | +41.7% | -4.2% | +32.0% | +22.5% | +91.6% | +13.7% | +18.6% | +4.5% | +3.0% | +30.2% | +18.9% | |
| – | – | – | – | – | +9,573.8% | -0.1% | +0.0% | +0.0% | +0.0% | +0.0% | – | – | – | +46.2% | +72.6% | +7.8% | +8.0% | -54.2% | +147.3% | -3.1% | +100.1% | – | – | – | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | |
| – | +29.9% | -5.5% | -16.5% | +66.3% | +46.2% | -45.2% | -5.7% | +32.6% | -37.5% | +90.0% | +112.5% | -9.0% | -5.3% | +33.0% | -8.0% | +156.4% | +56.7% | +30.2% | +43.8% | +21.7% | +38.1% | +42.5% | +26.6% | -0.6% | +70.2% | +20.8% | +14.6% | +13.0% | +6.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +233.9% | +105.0% | +68.6% | +78.3% | +40.5% | +47.6% | +74.1% | +22.9% | +17.0% | +16.2% | +13.0% | |
| – | +18.5% | +6.9% | +1.4% | +11.8% | +19.7% | +4.4% | +14.8% | +11.3% | -0.4% | +3.6% | +14.4% | +18.8% | +1.2% | +3.9% | +9.3% | +27.3% | -3.5% | +2.0% | +1.6% | +0.9% | -0.3% | -1.0% | -0.2% | +0.4% | -2.5% | +1.2% | +0.2% | +1.2% | -5.6% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.